Zimmer Biomet

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zimmer Biomet and other ETFs, options, and stocks.

About ZBH

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. 

CEO
Ivan Tornos
CEOIvan Tornos
Employees
17,000
Employees17,000
Headquarters
Warsaw, Indiana
HeadquartersWarsaw, Indiana
Founded
1927
Founded1927
Employees
17,000
Employees17,000

ZBH Key Statistics

Market cap
16.17B
Market cap16.17B
Price-Earnings ratio
26.09
Price-Earnings ratio26.09
Dividend yield
1.04%
Dividend yield1.04%
Average volume
1.98M
Average volume1.98M
High today
$91.50
High today$91.50
Low today
$82.05
Low today$82.05
Open price
$87.60
Open price$87.60
Volume
6.95M
Volume6.95M
52 Week high
$108.29
52 Week high$108.29
52 Week low
$82.05
52 Week low$82.05

Stock Snapshot

As of today, Zimmer Biomet(ZBH) shares are valued at $82.33. The company's market cap stands at 16.17B, with a P/E ratio of 26.09 and a dividend yield of 1.0%.

As of 2026-04-28, Zimmer Biomet(ZBH) stock has fluctuated between $82.05 and $91.50. The current price stands at $82.33, placing the stock +0.3% above today's low and -10.0% off the high.

The Zimmer Biomet(ZBH)'s current trading volume is 6.95M, compared to an average daily volume of 1.98M.

During the past year, Zimmer Biomet(ZBH) stock moved between $82.05 at its lowest and $108.29 at its peak.

During the past year, Zimmer Biomet(ZBH) stock moved between $82.05 at its lowest and $108.29 at its peak.

ZBH News

TipRanks 56m
Zimmer Biomet: Earnings Beat Masks Slowing Growth and Leadership Uncertainty, Supporting Hold Rating

Needham analyst Michael Matson has maintained their neutral stance on ZBH stock, giving a Hold rating on April 24. Claim 55% Off TipRanks Unlock hedge fund-leve...

The Motley Fool 3h
Zimmer Biomet Q1 2026 Earnings Transcript

Image source: The Motley Fool. Tuesday, April 28, 2026 at 8:30 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer — Ivan Tornos Executive Vice Pre...

Zimmer Biomet Q1 2026 Earnings Transcript
Reuters 6h
Medical device maker Zimmer Biomet raises annual profit forecast, announces CFO departure - Reuters

...

Medical device maker Zimmer Biomet raises annual profit forecast, announces CFO departure - Reuters

Analyst ratings

61%

of 31 ratings
Buy
29%
Hold
61.3%
Sell
9.7%

More ZBH News

Nasdaq 7h
Zimmer Biomet Q1 Earnings and Revenues Top Estimates

Zimmer Biomet (ZBH) came out with quarterly earnings of $2.09 per share, beating the Zacks Consensus Estimate of $1.86 per share. This compares to earnings of $...

Zimmer Biomet Q1 Earnings and Revenues Top Estimates
Nasdaq 7h
Zimmer Biomet Holdings Q1 26 Earnings Conference Call At 8:30 AM ET

(RTTNews) - Zimmer Biomet Holdings Inc. (ZBH) will host a conference call at 8:30 AM ET on April 28, 2026, to discuss Q1 26 earnings results. To access the liv...

Zimmer Biomet Holdings Q1 26 Earnings Conference Call At 8:30 AM ET
TipRanks 8h
Zimmer Biomet Announces CFO Departure and Interim Successor

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

TipRanks 8h
Zimmer Biomet reports Q1 EPS $2.09, consensus $1.86

Reports Q1 revenue $2.09B, consensus $2.07B. “We are off to a solid start to the year – strategically, operationally and financially,” said Ivan Tornos, chairma...

Nasdaq 8h
Zimmer Biomet Holdings CFO Suketu Upadhyay Steps Down, Paul Stellato To Be Interim CFO

(RTTNews) - Tuesday, Zimmer Biomet Holdings, Inc. (ZBH) announced that Suketu Upadhyay will step down from the position of Chief Financial Officer and Executive...

Zimmer Biomet Holdings CFO Suketu Upadhyay Steps Down, Paul Stellato To Be Interim CFO
TipRanks 5d
Zimmer Biomet’s XtraFix Study Update: What Investors Should Know

Zimmer Biomet Holdings (ZBH) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharpe...

Simply Wall St 5d
ROSA Robotics Push Into Outpatient Joint Replacement Could Be A Game Changer For Zimmer Biomet

The global orthopedic implants market is projected to reach about US$88.60 billion by 2036 from roughly US$55.80 billion in 2026, while Zimmer Biomet’s ROSA pla...

ROSA Robotics Push Into Outpatient Joint Replacement Could Be A Game Changer For Zimmer Biomet

People also own

Based on the portfolios of people who own ZBH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.